Alopexx
North America, Massachusetts, United States, Concord
Description
Alopexx partners with innovative entrepreneurs to build successful new companies. We will in-license novel therapies or medical devices
Investor Profile
Alopexx has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 50% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Series D rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Health Care, Health Diagnostics.
Stage Focus
- Series Unknown (50%)
- Series D (50%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Health Diagnostics
- Medical Device
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Alopexx frequently co-invest with?
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
What are some of recent deals done by Alopexx?
Find More Investors Like Alopexx
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
